Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is a common pulmonary malignant disease with a poor prognosis. There were limited studies investigating the influences of the tumor immune microenvironment on LUAD patients’ survival and response to immune checkpoint inhibitors (ICIs). METHODS: Based on TCGA-LU...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Ming, Li, Anping, Zhou, Linghui, Chu, Qian, Luo, Suxia, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139885/
https://www.ncbi.nlm.nih.gov/pubmed/33386920
http://dx.doi.org/10.1007/s00262-020-02817-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139885/
https://www.ncbi.nlm.nih.gov/pubmed/33386920
http://dx.doi.org/10.1007/s00262-020-02817-z

Ejemplares similares